InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018)
InspireMD (NSPR) posted quarterly Preferred Stock Liabilities of $2.3 million for Q2 2018, up 27.26% quarter-over-quarter from $1.8 million in Q1 2018.
InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
InspireMD's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $2.3 million for Q2 2018.
- In Q2 2018, Preferred Stock Liabilities changed N/A year-over-year to $2.3 million; the TTM figure through Jun 2018 stood at $2.3 million (changed N/A YoY), while the FY2017 annual figure was $274000.0, changed N/A from the prior year.
- Preferred Stock Liabilities for Q2 2018 stood at $2.3 million, up from $1.8 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $2.3 million in Q2 2018, with the low at $274000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | InspireMD | 58.54 Mn | 4.33 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 2.26 Mn |
| Mar 31, 2018 | 1.78 Mn |
| Dec 31, 2017 | 274,000.00 |